US$ 28.02
glp 1 lower triglycerides GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Frontiers | Exploring the multifaceted
Description
In fiscal 2024, there were 9,464 active duty soldiers who received at least one anti-obesity medication

Quantification and statistical analysis Statistical analyses were performed using GraphPad Prism 10.1.1 (GraphPad) and figures were generated using either GraphPad Prism or CorelDraw X8 (Corel)

Negative Effects A study from the University of Colorado Anschutz Medical Campus found that GLP-1 RAs are associated with an increased fracture risk in obese patients without diabetes, particularly in those with a body mass index (BMI) over 40 and aged over 68

This is where GLP-1 microbiome science becomes especially relevant, because prebiotic-driven microbial activity helps connect gut ecology, enteroendocrine signaling, appetite regulation, and metabolic balance
